mine on glutkhione and amino acid levels in the nephron. Am. J. Physiol. 231(5): 1536-1540.
1976. -The effect of i-methionine-DL-sulfoximine (MSO) on renal glutathione concentration and aspartic acid transport has been studied by analyses of parts of individual freeze-dried glomeruli, early and late proximal convoluted, early and late proximal straight, and distal straight and convoluted tubules, and patches from thinlimb and papilla areas. Glutathione normally varies threefold along the kidney nephron, being highest in the convoluted and early straight proximal tubule, lowest in the distal straight tubule. Large loads of aspartate cause 20% diminution of glutathione in outer cortex, due entirely to changes in proximal tubule segments. MS0 alone lowers glutathione 90% in all parts of the proximal tubule, with no change elsewhere. MS0 does not affect the large increase in aspartate in proximal tubules caused by saturating aspartate loads, suggesting that glutathione is not directly involved in transport of this amino acid. Aspartate loads cause a large increase in renal glutamine, which is especially marked in the proximal straight tubule. MS0 effectively blocks this increase and depresses tissue glutamine below normal levels.
kidney; aspartate transport; glutamine; glutamate; nephron segments THE 
SYNTHESISANDDEGRADATION
Of glutathione via the Y-d utamyl cycle has been proposed by Meister (10, 11, 13, 14) as a general mechanism for amino acid transport across cell membranes. The validity of this proposal might be tested with an agent capable of blocking the cycle.
Such an agent is L-methionine-,nL-sulfoximine , which can decrease glutathione synthesis and glutathione content in liver and kidney (1'7, 19) , presumably by inhibition of y-glutamyl cysteine sy ,nthetase (19). This enzyme has been shown to be decreased in kidney after MS0 treatment (15).
After administration of a large load of aspartate, those segments of the renal tubule that are responsible for reabsorptive amino acid transport accumulate high concentrations of this amino acid (2). It was thought that the validity of the Meister theory, insofar as it applies to aspartate, might be tested by comparing the effects of MS0 on glutathione and aspartate concentrations in different parts of the nephron after giving a large load of aspartate. It also seemed possible that if the theory were correct, amino acid loads which exceed renal transport capacity might in themselves decrease glutathione levels in transporting segments by sequestering glutathione components at intermediate steps of the y-glutamyl cycle.
Modest decreases in glutathione in the proximal tubule were in fact observed after giving large loads of aspartate. However, the data to be presented also show that MS0 causes much more drastic decreases in glutathione of the proximal segments of the nephron and yet do not diminish the accumulation of aspartate from an aspartate load. In contrast, the accumulation in proximal tubules of glutamine, which normally accompanies aspartate accumulation, was blocked by MSO. (Glutamine synthetase is another enzyme inhibited by the sulfoximine.) PROCEDURE 
Aninkals
Male Sprague-Dawley rats (Zivic-Miller, Inc.), weighing 250-300 g, fed on Purina laboratory chow were used. They were injected with trypan blue (0.1 mg/g), 16-20 h before treatment, as a visual aid in distinguishing proximal convoluted tubules (12). L-Methionine sulfoximine was injected intraperitoneally 100 min prior to removal of kidneys. This was prior to the onset of convulsions, which at the dosage level used (2.5 mmol/kg) began at about 2 h. The amino acid loads were given on a schedule of combined intraperitoneal and subcutaneous injection which provided steady plasma levels for at least 10 min prior to kidney removal (2). When both MS0 and aspartate were given, inulin was also injected in order to permit direct comparison with data from animals in a previous study (2). Blood for plasma was obtained from the tip of the tail 1 min before kidney removal.
Kidney Samples
Rats were briefly anesthetized with ether and the kidneys removed and dropped within 1 s into Freon-12 (CCl,F,) chilled to its freezing point (-160°C) with liquid N,. The frozen tissue was stored at -60°C.
For preliminary studies, a cone of kidney was cut freehand at -2OOC into four major regions as described by Waldman and Burch (25). These were outer cortex, inner cortex plus outer stripe of medulla, inner stripe of medulla, and papilla. HClO, extracts of these regions were made at -20°C as described previously (2).
The general technique for isolating and weighing small identified freeze-dried samples has been described in detail (8). The specific procedure for kidney and the identification of various parts of the nephron have also been described (2).
Materials.
Most of the enzymes and biochemicals, including Lmethionine sulfoximine, were from Sigma Chemical Co., 5,5'-dithiobis(2nitrobenzoic acid) (Ellman reagent) was from Aldrich Chemical Co., 6-P-gluconate-dehydrogenase was from Boehringer Mannheim.
Analytical Methods
Glutathione analysis. The glutathione method will be described in detail elsewhere. It is based on the method of Tietze (23) and depends on the ability of glutathione and glutathione reductase (EC 1.6.4.2 yeast) to catalyze the oxidation of NADPH by Ellman's reagent (5). The method does not distinguish between oxidized and reduced glutathione. For each mole of glutathione (as GSH), about 100 mol of NADP+ are formed. For larger samples (5-50 pmol) from extracts of gross kidney regions, the NADP+ was directly determined fluorometritally. (Excess NADPH was first destroyed with acid, after which the NADP+ was reduced back to NADPH with glucose-6-P plus glucose-6-P-dehydrogenase, and the fluorescence measured.) For smaller samples (0.03-0.5 pmol) from individual nephron segments, initial steps were made in aqueous droplets in oil wells (9) and the sensitivity increased by enzymatic cycling.
Aspartate, glutamate, and glutamine measurement. The same procedures were used as described previously for aspartate (2), glutamate (2), and glutamine (3). In the case of glutamine, the procedure was modified to a) increase useful sensitivity (by reducing volumes), b) diminish loss of glutamine (by heating at a lower temperature in the first step), and c) insure complete removal of glutamate by including H,O, in the second step (8).
Step 1. S amples are added to 0.1 ~1 of 5 mM HCl in an oil well and heated 20 min at 50°C.
Step 2. 0.1 ~1 is added of 100 mM Tris-HCl, pH 8.4, containing 1 mM NAD+, 0.6 mM ADP, 200 pg/ml glutamic dehydrogenase (EC 1.4.1.3) and 0.06% H,O,.
Step 3. After 30 min at 20-25"C, 0.05 ~1 is added of 5 pg/ml solution of catalase (EC 1.11.1.6) in 20 mM Tris-HCl, pH 8.
Step 4. After 10 min at 20-25°C 0.1 ~1 is removed (for glutamate assay) and to the remainder is added 0.05 ~1 of 0.15 N HCl.
Step 5. After a few minutes, 0.2 ~1 is added of 25 ,ug/ml glutaminase (EC 3.5.1.2, E. coli) in 100 mM Na acetate buffer, pH 4.9, containing 0.4 mM EDTA, and O.i% BSA.
Step 6. After 30 min at 20-25°C 0.2 ~1 is added of glutamate reagent which contained 120 mM Tris-HCl buffer, pH 9.4, and all the other substances as in step 2 except lower NAD+, 0.2 mM, and H,O, was omitted.
Step 7. After 30 min at 20-25°C 0.3 ~1 of 0.1 N NaOH is added.
Step 8. After 30 min at 80°C 10 ~1 of cycling reagent are added (6) with 50 pg/ml of alcohol dehydrogenase and 5 pg/ml of malic dehydrogenase.
Step 9.
After 60 min at 20-25OC. 2 ul of 0.5 N NaOH are added.
Step 10. After 15 min at 95"C, 10 ~1 are transferred into a fluorometer tube containing 1 ml of indicator reagent (25 mM 2-amino-2-methyl-l-propanol-HCl buffer, pH 10.0, with 200 PM NAD+, 10 mM glutamate, and 5 cg/ ml of malic dehydrogenase, and 2 pg/ml of aspartate aminotransferase (EC 1.1.1.37, 2.6.1.1). Final reading is made after the reaction is complete (about 8 min). Glutamine standards (0.3-1.5 pmol) are incorporated in the first step reagent (HCl).
RESULTS

Glutathione Distribution in Kidney and Effect of MS0
Among the four gross subdivisions of normal kidney, glutathione is highest in the outer cortex and decreases progressively to about 40% of the maximum in the papilla (Fig. 1) . Examination of different parts of single nephrons (Fig. 2) shows that this unequal distribution is due to the existence of peak glutathione levels in the proximal convoluted and early straight segments, intermediate levels in late proximal straight and distal convoluted segments, and low levels elsewhere. (Note that the data in Fig. 2 are on a dry weight basis.)
MS0 causes a large decrease in glutathione in outer cortex with successively smaller decreases in deeper gross zones, so that the resulting levels were about the same in all gross subdivisions (Fig. 1) . This is seen (Fig.  2) to be due to a profound depression of glutathione in all parts of the proximal tubule, with little or no change elsewhere. The ratio between glutathione in the early part of the proximal straight tubule to that in the distal convoluted tubule falls from 1.4 on the controls to 0.1 after MSO. Effect of Amino Acids, Glycylglycine, and Glucose on Renal Glutathione Large loads of aspartate caused a modest but statistically significant (P < 0.001) depression of glutathione in the outer cortex ( Table 1 ). The same may be true for glycylglycine and glutamate, but not enough animals were studied to be sure. Palekar et al. (17) observed similar changes in whole kidney with glycylglycine and glutamate. They did not see any effect with a glutamine load of 1.67 mmol/kg. Even the higher loads used here (2 and 4 mmol/kg) do not cause appreciable decreases. The glutathione decrease after aspartate loads is shown . @'lg tubul 2) to be due exclusively tocha .nges in the proximal .e, invol .ving particularly the convol uted portion. Glucose loads large enough to exceed the tubular maximum did not cause significant changes in glutathione (Table 1) .
Paradoxically, MS0 and a large aspartate load (each of which alone produced a fall in glutathione) when given in combination caused a somewhat smaller decrease in glutathione than MS0 alone ( Figs. 1 and 2 ). Possibly this is due to the concomitant increase in glutamate which has been shown to be capable of reversing the MS0 inhibition of y-glutamyl cysteine synthetase (19) .
Kidney Aspartate and Glutamate Afier MS0 Treatment MS0 had,essentially no effect on normal renal aspartate or on the aspartate increase after a large load of the amino acid (Figs. 1 and 3) . The lack of effect on the BREHE, CHAN, ALVEY, AND BURCH proximal tubules after an aspartate load (Fig. 3) clearly indicates that reabsorptive aspartate transport has not been interfered with. This was confirmed by measurements based on urinary spillage of approximately threshold aspartate levels. This is also supported by the difference observed in gross subdivisions of kidney between tissue levels after subthreshold and above threshold aspartate loads (Fig. 1) . A load above threshold (4.5 mmol/kg) causes accumulation of a great deal of aspartate in the papilla and inner stripe of the medulla due to unabsorbed aspartate in the concentrated tubular urine (2). A subthreshold aspartate load (2.7 mmol/kg) causes no change in inner stripe or papilla because the tubular urine is nearly free of aspartate (2). MS0 does not affect these results (Fig. 1) .
As previously shown (2), an aspartate load causes large increases in glutamate in the proximal tubule. This is probably partly due to the large increase which occurs in plasma glutamate.
(The kidney is presented with a large glutamate load which is filtered and reabsorbed by proximal tubules where it accumulates.) Judging from changes in the outer and inner cortex, pretreatment with MS0 decreases this tubular accumulation, even though it does not have much effect on plasma glutamate (Fig. 4) . MS0 also decreases gluta- The amino acids and glucose were given in divided doses, the first by intraperitoneal injection and the subsequent ones by subcutaneous injection.
Glycylglycine was given as a single intraperitoneal injection.
(see PROCEDURE) . The abbreviations are the same as for Fig. 1 An aspatate load causes large increases in glutamine in all four gross subdivisions of the kidney (Fig. 4B ). The increase is especially marked in the proximal straight tubule (Fig. 5 ). This probably cannot be explained by the small increase in plasma glutamine (about 30%), but could be secondary to the increase in renal glutamate (see above and Fig. 4& . There is no increase in patches of tissue from the thin-limb area, and only modest increases occur in the distal tubule and papilla. MS0 not only prevents the rise in renal glutamine , but also depresses the tissu .e levels be low those seen normally in the absence of an amino acid load (Figs. 4B and 5 ). MS0 1 a so profoundly depresses plasma glutamine levels, with or without an aspartate load (Fig. 4B ), but th is d oes not appear to be the cause of the tissue glutamine changes since tissue levels do not correlate with plasma levels. As pointed out, an aspartate load in normal animals causes a large increase in tissue glutamine without a comparable rise in plasma glutamine. Similarly, in the presence of MSO, aspartate causes, without essential change in plasma glutamine, a tissue glutamine increase which is large percentagewise, although small in absolute terms. MS0 is known to inhibit glutamine synthetase (7, 16, 18, 20) . It seems likely that MS0 is severely inhibiting this enzyme both in the liver (to account for the fall in plasma glutamine) and in the kidney (to explain the fall in tissue glutamine 
